Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
PFC Premier Financial Corp (OHIO)
TWTR Twitter Inc
BCEI Bonanza Creek Energy Inc
RNGR Ranger Energy Services Inc
$RFTREES Refinitiv Eurozone ESG Select Index
BAC Bank of America Corp
DIS Walt Disney Co
AAPL Apple Inc
MCD McDonald's Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Premarket

Last Trade
Delayed
$36.81
0.06 (0.16%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$36.75
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
1,356,171

10-day average volume:
33,804,846
1,356,171

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, January 14, 2021
Pfizer's XALKORI(R) (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI(R) (crizotinib) for the treatment of pediatric patients 1 year of age and older and young...(BusinessWire)

January 13, 2021
Opioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America

The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 billion by 2027 while exhibiting a CAGR of 8.7% between 2020 and 2027. The growth is attributable to the increasing focus by the government...(Globe Newswire)

January 12, 2021
COVID-19 Creating Growth Opportunities for Respiratory Drugs Market; Market to Cross USD 25,500 million by the End of 2027 Due to Soaring Burden of Chronic Respiratory Diseases Worldwide

With availability of limited preventive or therapeutic interventions for respiratory viruses resulting in morbidity and mortality globally, there is significant increase in investments through authoritative bodies for research and development...(Globe Newswire)

Thinking about trading options or stock in Plug Power, Pfizer, Carnival Corp, American Airlines, or Bilibili?

InvestorsObserver issues critical PriceWatch Alerts for PLUG, PFE, CCL, AAL, and BILI. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to...(BusinessWire)

Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced that Pfizer Inc. (NYSE: PFE) has...(BusinessWire)

Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative

--New investments include companies focused on Oncology, Rare Disease, and Inflammation & Immunology Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech...(BusinessWire)

January 08, 2021
CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy

CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD), celebrates Pfizer Inc's (NYSE: PFE) announcement surrounding the first dosing of a patient with Duchenne in their Phase III gene...(BusinessWire)

Thinking about trading options or stock in Nio, Plug Power, Pfizer, Sorrento Therapeutics, or BioNTech?

InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer-BioNTech COVID-19-Impfstoff lost in vitro neutralisierende Antikorperantwort gegen SARS-CoV-2 mit einer Mutation aus, die mit einer schnellen Ubertragung assoziiert wird

New York und Mainz, Deutschland 08. Januar 2021 -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in vitro-Studie bekannt, die zeigen, dass Personen, die den Pfizer-BioNTech-COVID-19-Impfstoff erhalten haben...(Thomson Reuters ONE)

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

New York and Mainz, Germany, January 8, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies...(Thomson Reuters ONE)

January 07, 2021
Thinking about trading options or stock in Pfizer, Tesla, General Motors, JPMorgan Chase, or UnitedHealth Group?

InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GM, JPM, and UNH. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy

Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate PF-06939926 in boys with Duchenne muscular...(BusinessWire)

ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology

ImaginAb Inc., a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. (NYSE: PFE) to supply 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T...(PR Newswire)

January 06, 2021
Thinking about buying stock in Citigroup, Pfizer, CleanSpark, FuelCell Energy, or BP?

InvestorsObserver issues critical PriceWatch Alerts for C, PFE, CLSK, FCEL, and BP. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy

Dewpoint Therapeutics, the biomolecular condensates company, today announced a new research collaboration with Pfizer (NYSE: PFE) for the development of potential therapeutics for the treatment of myotonic dystrophy type 1, DM1, a rare genetic...(PR Newswire)

January 05, 2021
Thinking about trading options or stock in Pfizer, Tesla, Goldman Sachs, Caterpillar, or Walmart?

InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GS, CAT, and WMT. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer leadership at the 39th Annual J.P. Morgan Healthcare Conference to be held virtually. (BusinessWire)

January 04, 2021
Thinking about trading options or stock in Nio, Pfizer, CleanSpark, Roku, or Apple?

InvestorsObserver issues critical PriceWatch Alerts for NIO, PFE, CLSK, ROKU, and AAPL. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for somatrogon, a long-acting human growth hormone that...(BusinessWire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.